13F Holdings
中文EN

ADGM Adagio Medical Holdings, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 2006986 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY—
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE9.6%
ROA2.7%
ROIC (approx.)-89.9%
Asset turnover0.00x

Leverage & solvency

Liabilities / assets38.5%
Debt / equity0.11x
Current ratio0.90x
Interest coverage-5.77x

Cash quality & payout

Operating cash flow / net income-22.06x
Accruals ratio61.7%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31
Income statement
Revenue$0—$300,000
Cost of revenue$684,000—$1.31M
Gross profit-$684,000—-$1.01M
R&D expense$10.64M—$15.40M
SG&A expense$10.57M—$11.54M
Operating income-$21.89M—-$27.94M
Interest expense$2.91M—$1.66M
Pretax income-$25.32M—-$36.59M
Income tax$0$0$0
Net income-$25.08M—-$36.59M
EBITDA-$20.92M—-$27.41M
EPS (basic)-1.51—-48.16
EPS (diluted)-1.51—-48.16
Dividends declared per share——0.00
Weighted avg. shares (diluted)16.58M——
Balance sheet
Cash & equivalents$17.11M$20.59M$1.38M
Receivables—$35,000$71,000
Inventory$1.67M$2.57M$3.32M
Current assets$20.08M$25.35M$5.18M
PP&E, net$1.53M$1.96M$1.49M
Goodwill$13.97M$13.97M$0
Intangibles$6.97M$6.97M$0
Total assets$43.25M$48.45M$6.83M
Current liabilities$8.23M$7.76M$47.18M
Long-term debt$21.04M$17.18M$38.27M
Total debt$21.04M$17.18M$38.27M
Total liabilities$30.85M$28.54M$47.38M
Shareholders' equity$12.40M$19.91M-$132.02M
Net debt$3.94M-$3.41M$36.88M
Shares outstanding740,34815.20M779,908
Cash flow statement
Operating cash flow-$19.01M—-$25.65M
Capital expenditure$374,000—$333,000
Free cash flow-$19.39M—-$25.98M
Investing cash flow-$374,000—-$340,000
Financing cash flow$16.13M—$21.88M
Depreciation & amortization$970,000—$532,000
Stock-based compensation$1.48M—$442,000

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.